The intersection of artificial intelligence (AI) and healthcare presents a transformative frontier, particularly in the global fight against cancer. As healthcare systems worldwide grapple with rising ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
The Biden Administration is revising the rules for how agencies conduct cost-benefit analyses, and some CBA experts have expressed concerns. Earlier this year, President Biden issued an Executive ...
The recent Committee for Economic Development of Australia (CEDA) business luncheon held in Melbourne provided a venue for NBN Co chairman Ziggy Switkowski and Professor Henry Ergas to provide a ...
One problem: Voters aren't buying it. President Biden recently promised to “modernize” regulatory review, and that includes a major overhaul of how agencies measure the benefits and costs of their ...
The White House circumvented EPA’s career staff to write almost half of the cost-benefit analysis for the agency’s proposal ...
Current political and economic issues succinctly explained. Under both the Donald Trump and Joe Biden administrations, the U.S. government has had a seemingly unquenchable thirst for national security ...
The arrival of the palm oil industry in Indonesia’s Papua region has wrought more than five times as much environmental and social damage than the benefits it has delivered, according to a new ...
Toxic and even deadly train wrecks like the one in East Palestine, Ohio, are the high cost of a regulatory system rigged to favor big corporations over the needs of ordinary Americans. One of the ...
The introduction of lebrikizumab, a novel monoclonal antibody targeting interleukin-13 for severe atopic dermatitis (AD), was associated with cost savings of approximately €3.3 million over 3 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback